Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery
在进行清髓性异基因造血干细胞移植后,使用普乐沙福(一种CXCR4拮抗剂)可增强造血功能的恢复。
期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-016-0301-2
Green, Michael M B; Chao, Nelson; Chhabra, Saurabh; Corbet, Kelly; Gasparetto, Cristina; Horwitz, Ari; Li, Zhiguo; Venkata, Jagadish Kummetha; Long, Gwynn; Mims, Alice; Rizzieri, David; Sarantopoulos, Stefanie; Stuart, Robert; Sung, Anthony D; Sullivan, Keith M; Costa, Luciano; Horwitz, Mitchell; Kang, Yubin